Quarterly and annual results disclosed under 8-K Item 2.02.
SERA PROGNOSTICS, INC. reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
“On March 18, 2026, Sera Prognostics, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025 and providing business highlights.”
TECOGEN INC. reported three and twelve months ended December 31, 2025 results: revenue $27.07 million, net income net loss of $8.25 million.
“source chiller and marketing." NORTH BILLERICA, Mass., March 17, 2026 - Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products, reported revenues of $27.07 million and net loss of $8.25 million for the year December 31, 2025 compared to $22.62 million and net loss of $4.76 million for the same period in 2024, an increase in revenues of”
Lifeward Ltd. reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
“On March 18, 2026, Lifeward Ltd. (the “Company,” “we” or “us”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025.”
4D Molecular Therapeutics, Inc. reported year ended December 31, 2025 results: revenue $85 million.
“role expanded to Chief Commercial & Business Officer • Entered Strategic Partnership with Otsuka Pharmaceutical Co., Ltd. for 4D-150 in Asia-Pacific Region o 4DMT received $85 million upfront cash payment in the fourth quarter of 2025 and expects to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities”
Sachem Capital Corp. reported the year ended December 31, 2025 results: net income $1.8 million, or $0.04 per common share.
“Sachem Capital Corp. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the year ended December 31, 2025.”
EquipmentShare.com Inc reported quarter and year ended December 31, 2025 results: revenue $1,572 million for the fourth quarter and $4,379 million for the full-year, net income Net income of $65 million for the fourth quarter and $40 million for the full-year.
“EquipmentShare Reports Fourth Quarter and Full-Year 2025 Financial Results • Total revenue of $1,572 million for the fourth quarter and $4,379 million for the full-year. •”
Varagon Capital Corp reported the fiscal year ended December 31, 2025 results: EPS $0.24.
“Varagon Capital Corporation released an earnings presentation relating to its financial results for the fiscal year ended December 31, 2025.”
Spire Global, Inc. reported financial results for the quarter and year ended December 31, 2025.
“On March 18, 2026, Spire Global, Inc. (“Spire”) issued a news release announcing its financial results for the quarter and year ended December 31, 2025.”
Dogwood Therapeutics, Inc. reported Year ended December 31, 2025 results: net income Net loss attributable to common stockholders for the year ended December 31, 2025 was $35.5 million, EPS or $7.13 basic and diluted net loss per share.
“Net loss attributable to common stockholders for the year ended December 31, 2025 was $35.5 million, or $7.13 basic and diluted net loss per share”
Dogwood Therapeutics, Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income Net loss attributable to common stockholders for the fourth quarter of 2025 was $3.8 million, EPS or $0.26 basic and diluted net loss per share.
“Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results”
Hyperfine, Inc. reported full year 2026 results: revenue approximately $20 to $22 million. Guidance initiated.
“Management expects revenue for the full year 2026 to be approximately $20 to $22 million”
Hyperfine, Inc. reported full year ended December 31, 2025 results: revenue $13.56 million, net income $35.57 million, EPS $0.43 per share. Guidance reaffirmed.
“of 2025 net loss includes a gain from the change in fair value of warrant liabilities of $1.46 million. Full Year 2025 Financial Results • Revenues for the full year 2025 were $13.56 million, increasing 5.2% compared to $12.89 million in 2024. • Sold net 38 commercial Swoop® systems in 2025, compared to 48 in 2024. • Gross profit for the full year 2025 was $6.75”
Hyperfine, Inc. reported fourth quarter ended December 31, 2025 results: revenue $5.29 million, net income $5.91 million, EPS $0.06 per share.
“equity financing and the initial debt tranche, providing capital for commercial growth. Fourth Quarter 2025 Financial Results • Revenues for the fourth quarter of 2025 were $5.29 million, increasing 128% compared to $2.32 million in the fourth quarter of 2024. • Sold net 16 commercial Swoop® systems in the fourth quarter of 2025, compared to nine in the fourth”
PROKIDNEY CORP. reported financial results for the full year ended December 31, 2025.
“ProKidney Corp. (the "Company") issued a press release to announce its financial results for the year ended December 31, 2025.”
Cingulate Inc. reported financial results for the quarter ended December 31, 2025.
“today reported financial results for the quarter ended December 31, 2025, and provided a corporate update.”
Cingulate Inc. reported financial results for the year ended December 31, 2025.
“On March 18, 2026, Cingulate Inc. issued a press release announcing its financial results for the year ended December 31, 2025 and providing a business update.”
SailPoint, Inc. updated its full year of fiscal 2027 guidance (initiated).
“For the first quarter and full year of fiscal 2027, SailPoint expects”
SailPoint, Inc. updated its first quarter of fiscal 2027 guidance (initiated).
“For the first quarter and full year of fiscal 2027, SailPoint expects”
SailPoint, Inc. reported financial results for fiscal year ended January 31, 2026.
“On March 18, 2026 , SailPoint, Inc. (the “Company”) announced its financial results for the fiscal quarter and year ended January 31, 2026”
SailPoint, Inc. reported financial results for fiscal quarter ended January 31, 2026.
“On March 18, 2026 , SailPoint, Inc. (the “Company”) announced its financial results for the fiscal quarter and year ended January 31, 2026”
TEN Holdings, Inc. reported the twelve months ended December 31, 2025 results: revenue $3.1 million, net income approximately $19,498,000 or $(8.58) per share, EPS $(8.58) per share.
“capital markets, have positioned TEN Holdings to pursue growth and long-term shareholder value. Financial Results ● The Company reported fiscal year 2025 total revenues of $3.1 million, down 11.4% from $3.5 million in fiscal year 2024. The decrease was due to the following factors: a.) Virtual & Hybrid events decreased by $0.5 million, mainly due to an event”
GENERAL MILLS INC reported nine months ended February 22, 2026 results: revenue $13.8 billion, net income $1.9 billion, EPS $3.56.
“by lower adjusted operating profit and a higher adjusted effective tax rate, partially offset by lower net shares outstanding. Nine Month Results Summary • Net sales of $13.8 billion were down 7 percent, including a 5-point headwind from the net impact of divestitures and acquisitions and a 1-point benefit from foreign currency exchange. Organic net sales”
GENERAL MILLS INC reported third quarter ended February 22, 2026 results: revenue $4.4 billion, net income $303 million, EPS $0.56. Guidance reaffirmed.
“significant impacts from investments to improve brand remarkability, the North American yogurt divestitures, and an unfavorable trade expense timing comparison • Net sales of $4.4 billion were down 8 percent, including a 6-point headwind from the net impact of divestitures and acquisitions; organic net sales1 were down 3 percent • Operating profit of $525 million”
GENERAL MILLS INC reported fiscal quarter ended February 22, 2026 results: revenue $4.4 billion, net income $303 million, EPS $0.56. Guidance reaffirmed.
“significant impacts from investments to improve brand remarkability, the North American yogurt divestitures, and an unfavorable trade expense timing comparison • Net sales of $4.4 billion were down 8 percent, including a 6-point headwind from the net impact of divestitures and acquisitions; organic net sales1 were down 3 percent • Operating profit of $525 million”
HARTE HANKS INC reported calendar year ended December 31, 2025 results: revenue $159.6 million, net income -$0.8 million, EPS -$0.11 per basic and diluted share.
“compared to net loss of $2.4 million, or $0.33 per basic and diluted share, in the fourth quarter last year. Consolidated Full Year 2025 Results Full year revenues in 2025 were $159.6 million, down 13.9% from $185.2 million in 2024. Operating income in 2025 was $0.4 million, compared to operating income of $2.1 million in 2024 or a year over year decrease of 81.6%.”
HARTE HANKS INC reported fourth quarter ended December 31, 2025 results: revenue $39.9 million, net income $2.2 million, EPS $0.30 per basic and diluted share.
“relationships to drive profitable growth and long-term value for shareholders,” said David Fisher, President. Fourth Quarter Highlights • Total revenues for Q4 2025 were $39.9 million, down 15.4% compared to $47.1 million in Q4 2024. • Operating loss of $0.1 million compared to a loss of $1.6 million in the prior-year quarter. • Net income for the fourth”
WILLIAMS SONOMA INC reported fourth quarter and fiscal year ended February 1, 2026 results: EPS Q4 diluted EPS of $3.04; FY25 record diluted EPS of $8.84.
“Williams-Sonoma, Inc. announces strong fourth quarter and fiscal year 2025 results Q4 comparable brand revenue +3.2% Q4 operating margin of 20.3%; Q4 diluted EPS of $3.04 FY25 record diluted EPS of $8.84”
MICRON TECHNOLOGY INC reported third quarter of 2026 results: revenue $33.5 billion, EPS $18.90. Guidance reaffirmed.
“The following table presents Micron’s guidance for the third quarter of 2026: FQ3-26 GAAP (1) Outlook Non-GAAP (2) Outlook Revenue $33.5 billion ± $750 million $33.5 billion ± $750 million Gross margin Approximately 81% Approximately 81% Operating expenses Approximately $1.60 billion Approximately $1.40 billion Diluted earnings per share $18.90 ± $0.40 $19.15 ± $0.40”
MICRON TECHNOLOGY INC reported second quarter of fiscal 2026 results: revenue $23.86 billion, net income $13.79 billion, EPS $12.07 per diluted share.
“2026 – Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2026, which ended February 26, 2026. Fiscal Q2 2026 highlights • Revenue of $23.86 billion versus $13.64 billion for the prior quarter and $8.05 billion for the same period last year • GAAP net income of $13.79 billion, or $12.07 per diluted share • Non-GAAP net income”
Red Cat Holdings, Inc. reported year ended December 31, 2025 results: revenue $40.7 million.
“Full-year 2025 total revenue was $40.7 million”
XOMA Royalty Corp reported financial results for the fiscal quarter and year ended December 31, 2025.
“On March 18, 2026, XOMA Royalty Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.”
Macy's, Inc. reported the fourth quarter and fiscal year 2025 results: revenue net sales of $7.6 billion, net income GAAP net income was $507 million, EPS GAAP diluted earnings per share of $1.84; Adjusted diluted EPS of $1.67.
“today reported financial results for the fourth quarter and fiscal year 2025 and provided fiscal year 2026 guidance. Fourth Quarter 2025 Highlights • Macy’s, Inc. net sales of $7.6 billion exceeded guidance. • Macy’s, Inc. comparable sales 1 grew 1.8%, exceeding the company’s guidance. • Macy’s, Inc. achieved go-forward comparable sales growth of 2.0%. • Macy’s”
JABIL INC reported second quarter of fiscal year 2026 results: revenue $8.3 billion, EPS $2.08. Guidance raised.
“Inc. (NYSE: JBL), reported preliminary, unaudited financial results for its second quarter of fiscal year 2026. Second Quarter of Fiscal Year 2026 Highlights: • Net revenue: $8.3 billion • U.S. GAAP operating income: $374 million • U.S. GAAP diluted earnings per share: $2.08 • Core operating income (Non-GAAP): $436 million • Core diluted earnings per share”
URBAN ONE, INC. reported the three months ended December 31, 2025 results: revenue approximately $97.8 million, net income approximately $54.4 million, EPS $(12.24) per share (basic).
“For the three months ended December 31, 2025, net revenue was approximately $97.8 million, a decrease of 16.5% from the same period in 2024. The Company reported operating loss of approximately $54.0 million for the three months ended December 31, 2025, compared to operating loss of approximately $1.9 million for the three months ended December 31, 2024. Broadcast and digital operating income 1 was approximately $23.8 million for the three months ended December 31, 2025, a decrease of 38.3% from the same period in 2024. Net loss was approximately $54.4 million or $(12.24) per share (basic) for the three months ended December 31, 2025, compared to net loss of $35.7 million or $(7.81) per share (basic) for the same period in 2024.”
CervoMed Inc. reported financial results for the full year ended December 31, 2025.
“CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided corporate updates.”
CervoMed Inc. reported financial results for the fourth quarter ended December 31, 2025.
“CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided corporate updates.”
NETWORK-1 TECHNOLOGIES, INC. reported year ended December 31, 2025 results: revenue $150,000, net income $(2,420,000), EPS $0.11 per share, basic and diluted.
“Network-1 had revenue of $150,000 for the year ended December 31, 2025 as compared to revenue of $100,000 for the year ended December 31, 2024. Revenue in both 2025 and 2024 was from settlement agreements in litigations involving Network-1’s Remote Power Patent. Network-1’s operating expenses decreased by $265,000 in 2025 compared to 2024, primarily due to decreased professional fees and general and administrative expenses. Interest and dividend income for 2025 was $1,844,000 as compared to $1,897,000 for 2024. In addition, in 2025 Network-1 recorded realized and unrealized gains on marketable securities of $277,000 as compared to $177,000 in 2024. Network-1 reported a net loss of $2,420,000 or $0.11 per share, basic and diluted, for the year ended December 31, 2025, compared to a net loss of $3,034,000 or $0.13 per share, basic and diluted, for the year ended December 31, 2024.”
COMSCORE, INC. reported the fourth quarter and full year ended December 31, 2025 results: revenue $93.5 million, net income $3.0 million, EPS $6.40.
“to a special dividend of at least $47.0 million, enhancing alignment between common and preferred stockholders Q4 2025 Financial Highlights • Revenue for the fourth quarter was $93.5 million compared to $94.9 million in Q4 2024 • Net income of $3.0 million compared to $3.1 million in Q4 2024 • Adjusted EBITDA of $14.7 million compared to $14.2 million in Q4 2024 2026”
Star Equity Holdings, Inc. reported the full year ended December 31, 2025 results: revenue $172.2 million, net income $6.7 million, EPS 2.08 loss per diluted share.
“2025 Full-Year Summary • Revenue of $172.2 million increased 23% from 2024. Full year 2025 pro forma ("PF") (1) revenue of $224.7 million increased 7% from 2024. • Gross profit of $79.9 million increased 14% from 2024. PF gross profit of $95.0 million increased 6% from 2024 • Net loss attributable to common shareholders of $6.7 million, or 2.08 loss per diluted share, compared to net loss of $4.8 million, or $1.59 loss per diluted share, in 2024.”
Star Equity Holdings, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $56.8 million, net income $2.4 million, EPS $0.67 loss per diluted share.
“2025 Fourth Quarter Summary • Revenue of $56.8 million increased 69% from the fourth quarter of 2024. • Gross profit of $24.2 million increased 38% from the fourth quarter of 2024. • Net loss attributable to common shareholders of $2.4 million, or $0.67 loss per diluted share, versus net loss attributable to common shareholders of $0.6 million, or $0.20 loss per diluted share, in the fourth quarter of 2024.”
Neuronetics, Inc. reported full year 2026 results: revenue $160 million and $166 million. Guidance initiated.
“Expect full year 2026 revenue of between $160 million and $166 million”
Neuronetics, Inc. reported the twelve months ended December 31, 2025 results: revenue $149.2 million.
“Full year revenue of $149.2 million, up 99% as reported and 15% on an adjusted pro forma basis as compared to the full year 2024”
Neuronetics, Inc. reported the three months ended December 31, 2025 results: revenue $41.8 million, net income $(7.2) million, EPS $(0.10) per share.
“Fourth quarter 2025 revenue of $41.8 million, up 86% as reported and 23% on an adjusted pro forma basis as compared to the fourth quarter 2024”
DOCUSIGN, INC. reported the three months and the fiscal year ended January 31, 2026 results: revenue $836.9 million, net income $0.44 per diluted share, EPS $0.44 per diluted share.
“IAM represented over $350 million in ARR, and Docusign reached record highs for operating margin and free cash flow.” Fourth Quarter Financial Highlights ▪ Total revenue was $836.9 million, an 8% year-over-year increase including approximately 0.8% positive impact from foreign exchange rates . Subscription revenue was $819.0 million, an 8% year-over-year increase.”
ClearPoint Neuro, Inc. reported 2026 results: revenue $52.0 - $56.0 million. Guidance initiated.
“For 2026, we now expect revenues to be in the range of $52.0 - $56.0 million.”
ClearPoint Neuro, Inc. reported year ended December 31, 2025 results: revenue $37.0 million. Guidance reaffirmed.
“Reported revenue of $37.0 million for the full year 2025, an overall increase of 18% and 14% increase in organic growth over 2024 and signifying the eleventh consecutive year of growth”
ClearPoint Neuro, Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue $10.4 million. Guidance reaffirmed.
“Reported fourth quarter revenue of $10.4 million, including $1.2 million of IRRA flow revenue, representing 34% overall growth and 19% year-over-year organic growth compared with the fourth quarter of 2024”
Comstock Holding Companies, Inc. reported Fiscal Year 2025 results: revenue YTD revenue increased 23% to $62.9 million, net income YTD net income increased 17% to $17.1 million.
“YTD revenue increased 23% to $62.9 million - 28th consecutive quarter of YoY growth • YTD net income increased 17% to $17.1 million”
Pharma-Bio Serv, Inc. reported quarter ended January 31, 2026 results: revenue approximately $2.3 million, net income $32,860.
“biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2026 were approximately $2.3 million, a decrease of approximately $0.2 million when compared to the same period last year. Net income for the quarter ended January 31, 2026 was $32,860, an improvement of $24,324”
Citi Trends Inc updated its fiscal 2026 guidance (initiated).
“Expecting total sales growth of 6% to 8% with comparable store sales growth in the range of 5% to 7%”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.